ZTS

#394
Zoetis Inc. Class A Common Stock
77.6 6 USD
-0.78%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
77.56
77.96
Year Range
0.78
147.90
Daily Change
-0.78%
Monthly Change
-32.03%
6 month change
-39.47%
Year Change
-46.92%
Previous Close
78.2 7
Open
77.8 2
Low
77.5 6
High
77.9 6
Volume
2 629
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 32.56 B
  • Employee 15 K
  • Founded N/A
  • CEO Kristin C. Peck
  • Website www.zoetis.com
  • Headquarter New Jersey, United States
  • FIGI BBG0039320N9
  • Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
19.38
Price to sales ratio
5.44
Dividends per share
0.53
Dividend yield %
2.59

Zoetis Inc. Class A Common Stock

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

News